Research
Read how they describe their research on their University of Toronto profile.
Latest papers
Perspectives on Deprescribing Medications Among Patients Receiving Hemodialysis: A Qualitative Study.
American journal of kidney diseases : the official journal of the National Kidney Foundation · 2026 · senior author
Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.
Canadian journal of kidney health and disease · 2026
Scoping review of apixaban and rivaroxaban dosing for atrial fibrillation and venous thromboembolism in advanced chronic kidney disease.
International journal of clinical pharmacy · 2026
Latest funding
- $1,526,175
Pragmatic randomised trial of High Or Standard PHosphAte Targets in End-stage kidney disease - PHOSPHATE Canada (TARGET 2)
CIHR · 2018 · Co-investigator
- $314,416
Strategies for the management of Atrial Fibrillation in patiEnts receiving HemoDialysis (SAFE-HD)
CIHR · 2018 · Co-investigator
- $174,168
A pilot study to evaluate the feasibility and safety of performing a double blind, placebo-controlled, randomized controlled trial of The Routine use of SSRIs at the Initiation of End-stage Renal Disease Treatment (ROSIE)
CIHR · 2012 · Co-investigator
65 publications.
Perspectives on Deprescribing Medications Among Patients Receiving Hemodialysis: A Qualitative Study.
Abbaticchio A, Theodorlis M, Zlotnik N, Cross MS, Yazdani S, Kitchlu A, Wilson JA, Gagliardi AR, Battistella M
Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.
Sheffield M, Phelan E, Ratajczak N, Battistella M, Tennankore K, Odutayo A, Soroka S, Poyah P, More K, Naylor H, Kennie-Kaulbach N, Rainkie D, Wilson JA
Scoping review of apixaban and rivaroxaban dosing for atrial fibrillation and venous thromboembolism in advanced chronic kidney disease.
Gillis S, Phelan E, Pitman J, Trenaman S, Battistella M, Sanyal C, Daley C, Tennankore K, Gillis L, Wilson JA
Perspectives on potential pharmacist prescribing in an outpatient dialysis center: qualitative interviews with patients and clinicians.
Choi AS, Theodorlis M, Abbaticchio A, Battistella M
A systematic integrated technique for developing subject matter competencies in pharmacy education
Sauve J, Battistella M, Ho C, Austin Z
Characterization of Ganciclovir Dosing for the Management of Cytomegalovirus in Solid Organ Transplant Recipients Receiving Sustained Low-Efficiency Dialysis.
Zhang JA, Brown P, Harrison J, Battistella M
Prescribing patterns and medication costs in patients on maintenance haemodialysis and peritoneal dialysis.
Ghimire A, Lloyd AM, Bello AK, Battistella M, Ronksley P, Tonelli M
Strategies to Improve Equitable Access to Early Osteoarthritis Diagnosis and Management: An Updated Review.
Abenoja A, Theodorlis M, Ahluwalia V, Battistella M, Borkhoff CM, Hazlewood GS, Lofters A, MacKay C, Marshall D, Gagliardi AR
Optimizing Prescribing for Individuals With Type 2 Diabetes and Chronic Kidney Disease Through the Development and Validation of Algorithms for Community Pharmacists.
Morris J, Battistella M, Tennankore K, Soroka S, Kendell C, Poyah P, More K, Grandy M, Ransom T, Kennie-Kaulbach N, Rainkie D, Tran J, Abidi SSR, Abidi S, Fulford N, Neville H, Naylor H, Woodill L, Bishop A, Rodrigues G, Harpell D, Stewart M, Wilson JA
Medication Mindfulness: Implementation and Evaluation of a Single-Site, 6-Month Deprescribing Intervention for Patients on Hemodialysis.
Zlotnik N, Abbaticchio A, Theodorlis M, Cross MS, Kitchlu A, Wilson JA, Gagliardi AR, Battistella M
Pragmatic randomised trial of High Or Standard PHosphAte Targets in End-stage kidney disease - PHOSPHATE Canada (TARGET 2)
Principal investigators: Wald, Ron; Walsh, Michael W
Keywords: Dialysis; End-Stage Renal Disease; Phosphate; Randomized Control Trial
Strategies for the management of Atrial Fibrillation in patiEnts receiving HemoDialysis (SAFE-HD)
Principal investigators: Harel, Ziv; Wald, Ron
Keywords: Anticoagulation; Apixaban; Atrial Fibrillation; Direct Oral Anticoagulants; Feasibility; Hemodialysis; Warfarin
A pilot study to evaluate the feasibility and safety of performing a double blind, placebo-controlled, randomized controlled trial of The Routine use of SSRIs at the Initiation of End-stage Renal Disease Treatment (ROSIE)
Principal investigators: Jassal, Sarbijt V
Keywords: Antidepressant Therapy; Double Blind Randomized Controlled Trial; Feasibility Study; Incident Dialysis Patients; Pilot Data; Primary Prevention Study
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Medicine
- Nephrology
- Health Research Methods, Evidence, and Impact
- Internal Medicine
- Medicine/Nephrology
- Nursing
- Department of Family and Community Medicine
- Other
Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Aisha Lofters
Nursing
6 shared papers, latest 2025
Aisha Lofters
Department of Family and Community Medicine
6 shared papers, latest 2025
Amit Garg
Health Research Methods, Evidence, and Impact
6 shared papers, latest 2023
Ron Wald
Nephrology
4 shared papers, latest 2025
Marcello Tonelli
Medicine
4 shared papers, latest 2025
Karthik Tennankore
Internal Medicine
4 shared papers, latest 2026
Reem Adel Mustafa
Health Research Methods, Evidence, and Impact
3 shared papers, latest 2020
Catherine Clase
Medicine
3 shared papers, latest 2024
Deborah Marshall
Community Health Sciences
3 shared papers, latest 2024
Amber Molnar
Medicine
3 shared papers, latest 2020
Karen Cameron
Faculty
2 shared papers, latest 2019
Shanna Trenaman
College of Pharmacy
2 shared papers, latest 2026
Deborah Zimmerman
Faculty
2 shared papers, latest 2020
Zubin Austin
Faculty
2 shared papers, latest 2026
Ziv Harel
Nephrology
2 shared papers, latest 2025
Scott Brimble
Medicine
2 shared papers, latest 2020
Charmaine Lok
Nephrology
2 shared papers, latest 2025
Rita Suri
Medicine
2 shared papers, latest 2025
Rita Suri
Medicine/Nephrology
2 shared papers, latest 2025
Clara Bohm
Internal Medicine
2 shared papers, latest 2023
Fabrice Mac-Way
Medicine
2 shared papers, latest 2025
Certina Ho
Faculty
1 shared papers, latest 2026
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 25, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.